PT  - JOURNAL ARTICLE
AU  - Hitoshi Hashimoto
AU  - Nobuya Ogawa
AU  - Nami Hagihara
AU  - Kyohei Yamamoto
AU  - Kumiko Imanishi
AU  - Hiroyuki Nogi
AU  - Akiko Nishino
AU  - Takashi Fujita
AU  - Toshio Matsuda
AU  - Shigekazu Nagata
AU  - Akemichi Baba
TI  - Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Chimeras Reveal Domains That Determine Specificity of Vasoactive Intestinal Polypeptide Binding and Activation
AID  - 10.1124/mol.52.1.128
DP  - 1997 Jul 01
TA  - Molecular Pharmacology
PG  - 128--135
VI  - 52
IP  - 1
4099  - http://molpharm.aspetjournals.org/content/52/1/128.short
4100  - http://molpharm.aspetjournals.org/content/52/1/128.full
SO  - Mol Pharmacol1997 Jul 01; 52
AB  - Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) receptors are closely related G protein-coupled receptors with seven-transmembrane domains. The VIP receptor can bind both VIP and PACAP with high affinity, whereas the PACAP receptor binds only PACAP with high affinity. To elucidate the structural domains involved in a selectivity for VIP binding and the subsequent receptor activation, a series of chimeric receptors between the VIP and PACAP receptors was constructed, expressed in COS-7 cells, and analyzed for ligand binding and cAMP generation. All chimeric constructs bound PACAP with high affinity and subsequently activated cAMP generation similarly to the wild-type receptors. In contrast, profound differences were observed in the potencies of VIP for competition of 125I-labeled PACAP binding to both wild-type receptors and the chimeric receptors. The cAMP responses of these receptors generally correlated with the ability of VIP to compete for PACAP radioligand binding with the exceptions for some particular chimeras. In this report we demonstrate that several domains, including the amino-terminal extracellular domain, the transmembrane domains I and II, and the first extracellular loop of the VIP receptor, are important for the selectivity for VIP binding and responsiveness to VIP. We further show that the third extracellular loop and its proximal domains of the VIP receptor appear to be involved in the VIP recognition, especially the receptor activation process. On the other hand, the direct binding experiments of the VIP radioligand demonstrated that both wild-type receptors and all chimeric receptors have a high affinity binding site for VIP, although this high affinity VIP binding resulted in a biological response only in the VIP receptor or VIP receptor-like chimeras. This suggests that there is a nonbiologically relevant high affinity VIP-binding site within the rat PACAP receptor.